Crossmark

The activity of a herbal medicinal product of Phyllanthus niruri and Silybum marianum powdered extracts (Heptex®) in patients with apparent risk factors for nonalcoholic steatohepatitis: a phase II, multicentered, randomized, double-blind, placebo-controlled clinical trial

Crossref DOI link: https://doi.org/10.1186/s12906-024-04692-y

Published Online: 2025-01-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Shaker, Mohamed Kamal https://orcid.org/0000-0003-3238-4793
Hassany, Mohamed

Eysa, Basem

Adel, AbdulMoneim

Zidan, Ahmed

Mohamed, Shahnaz
License Information

Text and Data Mining valid from 2025-01-09

Version of Record valid from 2025-01-09
More Information

Article History

Received: 11 July 2023

Accepted: 29 October 2024

First Online: 9 January 2025

Declarations

:

: All experiments were performed in accordance with relevant international and local guidelines and regulations. The study protocol was approved by the Egyptian Ministry of Health and Population (MoHP) Research Ethics Committee (code: 3-2020/13), the National Hepatology and Tropical Medicine Research Institute (NHTMRI) Research Ethics Committee (code: ITH00001), and Ain Shams University Research Ethics Committee (code: P02c/2019-2022). Informed consent was obtained from all participants prior to conducting any study-related procedures.

: Not applicable.

: Shahnaz Mohamed is an employee of Natural Wellness. The rest of the authors declare no conflicts of interest.

Document is current

Any future updates will be listed below